Different factors underlie recurrent and de novo organ involvement in immunoglobulin G4-related disease

Rheumatology
Ichiro MizushimaMitsuhiro Kawano

Abstract

In IgG4-related disease (IgG4-RD), relapse including recurrent organ involvement (ROI) and de novo organ involvement (DNOI) occurs frequently during the clinical course. This study aimed to clarify the differences between the risk factors underlying ROI and DNOI in IgG4-RD. We retrospectively investigated factors related to ROI and DNOI in 86 IgG4-RD patients. For assessment of factors related to ROI and DNOI, we performed uni- and multivariate Cox regression analyses. On stepwise multivariate analysis, we applied the variables with P < 0.1 in the univariate analysis and the predictors of relapse suggested in past reports. During the mean follow-up period of 63.1 months, ROI was detected at 1.0-120 months after diagnosis in 20 patients, 4 of whom were not receiving glucocorticoid (GC) at the time of ROI. In contrast, DNOI was detected at 5.0-120 months after diagnosis in 15 patients, 8 of whom were not receiving GC at the time of DNOI. In the multivariate analysis, blood eosinophil counts at diagnosis [per 100/μl; hazard ratio (HR) 1.072 (95% CI 1.018, 1.129)] and continuation of GC [vs discontinuation or observation without GC; HR 0.245 (95% CI 0.076, 0.793)] had a significant impact on the time to DNOI, whereas age [HR 0.942 ...Continue Reading

References

Dec 5, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Shigeyuki KawaNorikazu Arakura
May 4, 2010·The Journal of Rheumatology·Yasufumi MasakiHisanori Umehara
Sep 8, 2011·Clinical and Experimental Nephrology·Mitsuhiro KawanoTakao Saito
Feb 10, 2012·The New England Journal of Medicine·John H StoneVikram Deshpande
May 17, 2012·Annals of the Rheumatic Diseases·Motohisa YamamotoYasuhisa Shinomura
Mar 19, 2014·Journal of Gastroenterology·Kazuichi OkazakiUNKNOWN Working Committee of the Japan Pancreas Society and the Research Committee for Intractable Pancreatic Disease supported by t
Jun 3, 2014·Orphanet Journal of Rare Diseases·Masahiro MaruyamaShigeyuki Kawa
May 20, 2015·Arthritis & Rheumatology·Zachary S WallaceJohn H Stone
Feb 19, 2016·Rheumatology·Zachary S WallaceJohn H Stone
Aug 21, 2016·Gut·Atsushi MasamuneUNKNOWN Research Committee of Intractable Pancreas Diseases in Japan
Feb 21, 2018·Journal of Gastroenterology·Kazushige Uchida, Kazuichi Okazaki

❮ Previous
Next ❯

Related Concepts

Related Feeds

Related Papers

Occupational Health & Safety
Simon Herriott
Health Data Management
Gary Baldwin
Hospitals & Health Networks
Dave Carpenter
Marketing Health Services
Carl Aquila, Colleen Burke
© 2021 Meta ULC. All rights reserved